Delivery Order SPE2DB25D3012-SPE2DB25FXAFS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Venclexta 100 mg tablets (120 count) with a ceiling value of $9,728.17. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The order is scheduled for completion by October 9, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Venclexta 100 mg tablets (120 count) at a ceiling value of $9,728.17. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is set for ultimate completion by May 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed price delivery order, valued at $58,369.02, represents a non-competitive, non-set-aside award and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $2,289.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Venclexta 100 mg tablets (28-count unit dosage). This non-set-aside competitive award is scheduled for completion by September 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Venclexta 50 mg tablet unit dose packages (quantity 7). This non-set-aside, competitively awarded contract is valued at $1,743.06 with a firm fixed price and is scheduled for completion by September 4, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a contract ceiling value of $19,456.34. This delivery order was issued under a firm fixed price arrangement with no set-aside designation, indicating competitive award. The ultimate completion date is set for September 30, 2025. As a child contract action, this delivery order derives from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (28-count units) valued at $2,289.70. The contract, awarded on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a firm fixed-price, non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAFSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Venclexta 100 mg tablets (120 count units) with a ceiling value of $19,456.34. This is a firm fixed-price delivery order with no set-aside designation, completed through competitive award procedures. The order is scheduled for completion by October 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle running through December 2026 that supports global pharmaceutical supply to military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company maintains extensive federal contract relationships with the Defense Logistics Agency and Defense Health Agency, supplying a comprehensive range of pharmaceuticals including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The Venclexta procurement supports the company's established role as a key pharmaceutical provider within the defense medical supply chain, delivering oncology and hematology medications to support military healthcare operations. All of AmerisourceBergen's reviewed contract awards have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement standards for medical product delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 9/18/25 |